OptMed(OMED)

从VEGF/DLL4双抗“三兄弟”的前世今生，分析双抗研发策略

同写意2022-05-14 21:40

撰文丨顾津明，同润生物CSO
编辑丨于靖
近日，Compass Therapeutics公布了其VEGF/DLL4（CTX-009）双特异抗体联合紫杉醇在治疗胆道癌（BTC）的2期临床中期研究成果，结果表明该双抗药物安全性良好，在24名患者中有10位病人平均治疗6个月后得到了客观缓解，ORR为42%（10/24），算不上惊艳，...查看全文

Horned_Reaper2019-04-23 19:41

$Oncomed制药(OMED)$ 查看全文

Horned_Reaper2019-03-09 00:21

$Oncomed制药(OMED)$ 0.848加点仓，希望可以像SEEL一样起飞查看全文

Horned_Reaper2019-02-28 05:25

$Oncomed制药(OMED)$ 看来要再洗掉几层皮！航班开始无限期延误...[好困惑]查看全文

Horned_Reaper2019-02-21 05:51

$Oncomed制药(OMED)$ 看来飞机超载，要洗一洗才能起飞查看全文

Horned_Reaper2019-02-16 02:56

$Oncomed制药(OMED)$ 晚了一点起飞查看全文

Horned_Reaper2019-01-07 22:55

$Oncomed制药(OMED)$ 请收起小桌板，调直座椅靠背，系好安全带！查看全文

Horned_Reaper2019-01-04 23:35

$Oncomed制药(OMED)$ 随时要起飞的节奏…查看全文

有为的股价小宝石2018-12-27 00:15

$Oncomed制药(OMED)$ 要开涨了啊查看全文

usbiostock2018-08-03 09:49

$OncoMed Pharmaceuticals, Inc. (OMED)$ 1. Navicixizumab单药治疗实体瘤临床1a期试验一线数据预计：2018年第4季度；2. Etigilimab单药治疗进展性/转移性实体瘤临床1a期试验一线数据预计：2018年第4季度；3. 现金：$79.9M。查看全文

$OncoMed Pharmaceuticals, Inc.(OMED)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2018-05-25 AccNo: 0001193125-18-175282 Size: 886 KB 网页链接

$OncoMed Pharmaceuticals, Inc.(OMED)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-08 AccNo: 0001564590-18-011826 Size: 5 MB 网页链接

$OncoMed Pharmaceuticals, Inc.(OMED)$ 8-K - Current report Filed: 2018-05-08 AccNo: 0001564590-18-011801 Size: 177 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$OncoMed Pharmaceuticals, Inc.(OMED)$ 美东时间 2018-05-08 盘后 披露财报，预期EPS -0.25 网页链接

$OncoMed Pharmaceuticals, Inc.(OMED)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-04-27 AccNo: 0001564590-18-009587 Size: 267 KB 网页链接

$OncoMed Pharmaceuticals, Inc.(OMED)$ DEF 14A - Other definitive proxy statements Filed: 2018-04-27 AccNo: 0001564590-18-009577 Size: 1 MB 网页链接

$OncoMed Pharmaceuticals, Inc.(OMED)$ 内部交易: 2018-04-24,SVP & General Counsel,Hager Alicia J. ,卖出,4051普通股, $2.68

$OncoMed Pharmaceuticals, Inc.(OMED)$ 内部交易: 2018-04-24,See Remarks,Gurney Austin ,卖出,4051普通股, $2.68

$OncoMed Pharmaceuticals, Inc.(OMED)$ 内部交易: 2018-04-24,总裁 & CEO,Lewicki John A. ,卖出,4557普通股, $2.68

$OncoMed Pharmaceuticals, Inc.(OMED)$ 内部交易: 2018-04-24,SVP, Clinical R&D,Stagg Robert ,卖出,4051普通股, $2.68